Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Gautier

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Diabetes & Metabolism|February 14, 1998
[Insulin sensitivity and hepatic glucose production: nycthemeral variations]J F Gautier, G Cathelineau
Annales D'Endocrinologie|July 23, 2011
Efficacy of saxagliptin as an add-on to oral monotherapy in the phase 3 clinical development program: predictive factors of the treatment response in type 2 diabetesJ-F Gautier, J-P Sauvanet
Diabetes & Metabolism|July 14, 2001
[Physical exercise and insulin sensitivity]J F Gautier, F Mauvais-Jarvis
Diabetes & Metabolism|February 7, 2009
How to measure hepatic insulin resistance?S-P Choukem, J-F Gautier
Annales D'Endocrinologie|October 30, 2010
Treatment of type 2 diabetes: New clinical studies and effects of GLP-1 on macrovascular complicationsS Lesven, J-F Gautier, R Maréchaud
Diabetes & Metabolism|August 3, 2010
Physical exercise for the prevention and treatment of type 2 diabetesC Sanz, J-F Gautier, H Hanaire
Diabetes & Metabolism|May 21, 1999
Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an updateC Weyer, J F Gautier, E Danforth
Journees Annuelles De Diabetologie De L'Hotel-Dieu|September 22, 2001
[How to treat and manage the black diabetic patient]J F Gautier, E Sobngwi, P Vexiau
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 1, 1995
Exercise in the management of non-insulin-dependent (type 2) diabetes mellitusJ F Gautier, A Scheen, P J Lefèbvre
Diabetes & Metabolism|July 22, 2008
Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetesJ-F Gautier, S-P Choukem, J Girard
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Diabetes & Metabolism|February 14, 1998
[Insulin sensitivity and hepatic glucose production: nycthemeral variations]J F Gautier, G Cathelineau
Annales D'Endocrinologie|July 23, 2011
Efficacy of saxagliptin as an add-on to oral monotherapy in the phase 3 clinical development program: predictive factors of the treatment response in type 2 diabetesJ-F Gautier, J-P Sauvanet
Diabetes & Metabolism|July 14, 2001
[Physical exercise and insulin sensitivity]J F Gautier, F Mauvais-Jarvis
Diabetes & Metabolism|February 7, 2009
How to measure hepatic insulin resistance?S-P Choukem, J-F Gautier
Annales D'Endocrinologie|October 30, 2010
Treatment of type 2 diabetes: New clinical studies and effects of GLP-1 on macrovascular complicationsS Lesven, J-F Gautier, R Maréchaud
Diabetes & Metabolism|August 3, 2010
Physical exercise for the prevention and treatment of type 2 diabetesC Sanz, J-F Gautier, H Hanaire
Diabetes & Metabolism|May 21, 1999
Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an updateC Weyer, J F Gautier, E Danforth
Journees Annuelles De Diabetologie De L'Hotel-Dieu|September 22, 2001
[How to treat and manage the black diabetic patient]J F Gautier, E Sobngwi, P Vexiau
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 1, 1995
Exercise in the management of non-insulin-dependent (type 2) diabetes mellitusJ F Gautier, A Scheen, P J Lefèbvre
Diabetes & Metabolism|July 22, 2008
Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetesJ-F Gautier, S-P Choukem, J Girard
Pageof 9